Skip to main content

Table 2 Cardiovascular magnetic resonance results in patients vs. controls

From: Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease

Variable Healhty Controls
N = 16
T2DM
N = 31
P value
LV end-diastolic volume, ml 159 ± 33 128 ± 33 0.004
Indexed LV end-diastolic volume, ml/m2 78 ± 19 64 ± 21 0.012
LV end-systolic volume, ml 49 ± 12 40 ± 17 0.087
Indexed LV end-systolic volume, ml/m2 23 ± 13 20 ± 16 0.168
LV stroke volume, ml 110 ± 22 87 ± 23 0.002
Indexed LV stroke volume, ml/m2 55 ± 25 45 ± 20 0.008
LV ejection fraction, % 69 ± 4 69 ± 8 0.786
LV mass index, g/m2 53 ± 15 60 ± 13 0.075
LV mass, g 115 ± 29 120 ± 31 0.534
LV mass/end-diastolic volume g/ml 0.75 ± 0.23 0.96 ± 0.18 0.001
  1. Values are mean ± standard deviations or percentages. T2DM indicates type 2 diabetes mellitus; CMR, cardiovascular magnetic resonance; LV, left-ventricular